type here...

CATEGORIES

Press Release

LATEST

1234...12Page 3 of 12

TRENDING

EDITORS CHOICE

First NASH Patient Dosed with CRV431 in Phase 2 ‘AMBITION’ Clinical Trial

Medika Life -
The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and F3 NASH patients

Clinics IV Life Launches a New Clinic Model to Change the Face of Charitable Maternal Care, Delivery to Impoverished Communities

Robert Turner, Founding Editor -
MAY 30, 2023, AUSTIN, TX – Clinics IV Life, a Texas-based not-for-profit led by a global team of global humanitarians working to counter the climbing...

FREOPP Study: How New York’s Single Payer Health Care Bill Affects the Working Poor

Medika Life -
The flawed design of the New York Health Act would be felt most acutely by low-income New Yorkers, a new FREOPP study finds. This Single-Payer Health

Unique Global Symposium Suggests Vital Shifts in Cancer Treatment

Medika Life -
More than 30 preeminent experts to present virtually; vast degree of structural disease change, high speed of cancer evolution, rarely considered until now

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories